Table 4.
Sensitivity analysis after excluding participants who occurred cancer within the first year and the first five years of follow-up.
| Groups | Cases/person-years | Adjusted models | |
|---|---|---|---|
| HR (95%CI) | p-value | ||
| Exclude CRC cases diagnosed within the first year of follow-up | |||
| T1 group | 153/385,550 | Ref | |
| T2 group | 178/383,401 | 1.09 (0.88, 1.68) | 0.655 |
| T3 group | 224/373,103 | 1.57 (1.11, 2.31) | 0.014 |
| P for trend | 0.001 | ||
| Exclude CRC cases diagnosed within the first 5 year of follow-up | |||
| T1 group | 68/385,252 | Ref | |
| T2 group | 90/383,063 | 1.22 (0.92, 2.39) | 0.351 |
| T3 group | 140/372,806 | 2.01 (1.58, 2.89) | < 0.001 |
| P for trend | < 0.001 | ||
Models were adjusted for age (every 10 years), sex, family income, educational background, marital status, BMI, TG, TC, TBIL, ALT, CRP, smoking status, drinking status, physical activity, sedentary lifestyle, tea consumption, high-fat diet, diabetes, hypertension, chronic kidney disease, and family history of cancer.